The Canadian Association of Pharmacy in Oncology (CAPhO) is a member-directed association that promotes, supports and advances oncology pharmacy practice. CAPhO is a recognized leader of oncology pharmacy in Canada, with members including pharmacists, pharmacy technicians, assistants and students. We support the provision of safe and effective oncology pharmacy services to oncology patients. Mentorship, education and research support are some of the ways that CAPhO contributes to member professional development. CAPhO advocates for oncology pharmacy excellence through the collaboration and engagement with healthcare providers, patients and other organizations.

Learn more about CAPhO through our website and our blogs (the Compass), and become a member today.

Latest News & Updates

Apobiologix, a division of Apotex Inc., expanded its product portfolio with the launch of a pre-filled autoinjector for Lapelga®, the company’s biosimilar pegfilgrastim that launched in Canada in 2019. Apobiologix, focused on the development of biosimilars for global markets, is the only biosimilar company to offer a pegfilgrastim autoinjector. The pre-filled syringe for Lapelga will continue to be available to patients.

Applications for the 3rd annual HOPE (Honouring Oncology Pharmacy Excellence) Awards in Pharmacy are now open!

Patients prescribed Fulphila have access to a multi-use and multi-patient copay program providing up to a maximum of 25% immediate financial assistance at pharmacy:

You are invited to attend a complimentary session on Applying Practical Strategies for the Treatment and Management of Patients with CLL.